Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen

Details for Australian Patent Application No. 2004246812 (hide)

Owner Ascend Therapeutics, Inc. Northweestern University

Inventors Palumbo, Andrew R.; Hilt, Dana C.; Few, Julius

Agent Wrays

Pub. Number AU-B-2004246812

PCT Pub. Number WO2004/110420

Priority 60/476,618 09.06.03 US

Filing date 2 June 2004

Wipo publication date 23 December 2004

Acceptance publication date 17 December 2009

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61L 26/00 (2006.01) Chemical aspects of, or use of materials for, liquid bandages

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2004/110420 Priority application(s): WO2004/110420

17 December 2009 Application Accepted

  Published as AU-B-2004246812

14 January 2010 Corrigenda

  Applications Accepted - Name Index Under the name Ascend Therapeutics, Inc. and Northweestern University, Application No. 2004246812, under INID (71) correct the co-applicant name to Northwestern University

15 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004246817-Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioidbased treatments

2004246811-Pharmaceutical formulations comprising amoxicillin and clavulanate